1-10 of 10
Signy Chow
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Clonal Hematopoiesis on Clinical Outcomes and Clonal Dynamics in Older Lymphoma Patients Receiving Chemotherapy

Rena Buckstein, Olivia Lopes, Amy J. M. McNaughton, Matthew C. Cheung, Lee Mozessohn, Lisa Chodirker, Kevin Imrie, Neil Berinstein, Signy Chow, Gillian Kupakuwana-Suk, Anne Parmentier, Prasha Sasitharakumar, Hubert Tsui, Liying Zhang, Michael J. Rauh
Journal: Blood
Blood (2023) 142 (Supplement 1): 442.
https://doi.org/10.1182/blood-2023-187778
Published: 2023
Journal Articles

Outcomes of Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) Receiving Intensive Vs. Non-Intensive First Line Treatment

Signy Chow, Alexandra Misura, Olga Bigun, Sila Usta, Renato Sasso, Dylan Gowlett-Park, Katarina Czibere, Rena Buckstein, Lee Mozessohn, Lisa Chodirker, James Kennedy, Hubert Tsui
Journal: Blood
Blood (2023) 142 (Supplement 1): 5840.
https://doi.org/10.1182/blood-2023-188464
Published: 2023
Journal Articles

Aberrant Splicing of MBD1 Reshapes the Epigenome to Drive Convergent Myeloerythroid Defects in MDS

He Tian (Tony) Tony Chen, Pratik Joshi, Emily Tsao, Joshua Xu, Soheil Jahangiri, Yulin Mo, David Kealy, Dylan Gowlett-Park, Katarina Czibere, Alexandra Misura, Olga Bigun, Renato Sasso, Dianne Chadwick, Sila Usta, Tina Khazaee, Signy Chow, Hubert Tsui, Mark D. Minden, Katherine S Bridge, Gang Zheng, Kristin J. Hope
Journal: Blood
Blood (2023) 142 (Supplement 1): 317.
https://doi.org/10.1182/blood-2023-180889
Published: 2023
Journal Articles

Searching for Service and Accessibility Excellence in Paroxysmal Nocturnal Hemoglobinuria in Canada: The Epic Program

Hayeong Rho, Kelsey Yang, Signy Chow, Christopher J. Patriquin
Journal: Blood
Blood (2021) 138 (Supplement 1): 4307.
https://doi.org/10.1182/blood-2021-151119
Published: 2021
Journal Articles

CPX351 Has Short Remission Duration but Is an Effective Bridge to Allogeneic Transplant in High Risk AML: Results from Canadian Real-World Multi-Centre Study

Claire Andrews, Taylor Young, Eshetu G Atenafu, M.Sc., P.Stat, Sarit E Assouline, MD MSc, Joseph M Brandwein, MD, Steven M Chan, MD PhD, Signy Chow, MD FRCP(C), Dina Khalaf, BSc, MSc, MD, Vikas Gupta, MD FRCP, FRCPath, Dennis Dong Hwan Kim, MD, Dawn Maze, MDFRCPC,MSc, Mark D. Minden, Caroline J McNamara, MBBS, Tracy Murphy, MDFRCP,FRCPath, David Sanford, MD, Aaron D Schimmer, MD PhD, Andre C. Schuh, Karen W.L. Yee, MD, Hassan Sibai, MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-142990
Published: 2020
Journal Articles

Targeted-Capture Sequencing Approach to V(D)J Rearrangement, Immunoglobulin (Ig) Translocation and Mutation Detection in Multiple Myeloma (MM): Potential Applications in Minimal Residual Disease (MRD) Analysis and Comparison to Multiparameter Flow Cytometry (MFC) in the Myeloma Canada Research Network (MCRN) 001 Study with Intravenous Busulfan and Melphalan (BuMel) Conditioning Followed By Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM)

Signy Chow, MD FRCP(C), Donna Reece, MD FRCP(C), Jonathan J. Keats, PhD, P. Leif Bergsagel, MD, Nizar J. Bahlis, MD, Paola Neri, MD, Giovanni Piza Rodriguez, MD, Michael Sebag, MD PhD, Darrell J White, MD, Kevin Song, MD FRCP(C), Terrance Comeau, MD, Christopher P. Venner, MD, Christine I Chen, MD FRCP(C), Jean Roy, MD, Martha L Louzada, MD, Julie Stakiw, MD FRCP(C), Andrea Kew, MDFRCP(C), Vishal Kukreti, MD FRCP(C), Anca Prica, MD FRCP(C), Rodger Tiedemann, MBChB, PhD, Mariela Aura Pantoja, PhD MSc, Harminder Kaur Paul, MSc, Trevor J. Pugh, PhD, Suzanne Trudel, MD FRCP(C)
Journal: Blood
Blood (2017) 130 (Supplement 1): 3057.
https://doi.org/10.1182/blood.V130.Suppl_1.3057.3057
Published: 2017
Journal Articles

Biomarker Driven Phase II Clinical Trial of Trametinib in Relapsed/Refractory Multiple Myeloma with Sequential Addition of the AKT Inhibitor, GSK2141795 at Time of Disease Progression to Overcome Treatment Failure: A Trial of the Princess Margaret Phase II Consortium

Suzanne Trudel, MD, Nizar J. Bahlis, MD, Christopher P. Venner, MD, Annette E Hay, MB ChB, Olena Kis, PhD, Signy Chow, MD FRCPC, Zhi Hua Li, MD, Ellen Nong Wei, MSc, Lisa Wang, PhD, Christine Tran, Smitha Udagani, Chantale Blattler, Trevor J. Pugh, PhD, Helen X Chen, MD, Amit Oza, MD
Journal: Blood
Blood (2016) 128 (22): 4526.
https://doi.org/10.1182/blood.V128.22.4526.4526
Published: 2016
Journal Articles

Mixed Fields on RHD Typing As an Indicator of Malignancy-Associated Loss of Heterozygosity on Chromosome 1p in Myeloid Neoplasm

Signy Chow, MD FRCPC, Jacob M Pendergrast, MD FRCPC, Gorka Ochoa-Garay, Vikas Gupta, MD FRCP, FRCPath, Muhammad Ejaz Munir, MBBS, FRCS, Cuihong Wei, PhD FCCMG, Kenneth J Craddock, MD FRCPC, Suzanne Kamel-Reid, PhD DABMG, FACMG, Christine Cserti-Gazdewich, MD FRCPC
Journal: Blood
Blood (2014) 124 (21): 5105.
https://doi.org/10.1182/blood.V124.21.5105.5105
Published: 2014
Journal Articles

A Link Between Hypercholesterolemia and Chronic Lymphocytic Leukemia

Signy Chow, MD FRCPC, Rena Buckstein, MD FRCPC, David Spaner, MD FRCPC, PhD
Journal: Blood
Blood (2014) 124 (21): 5630.
https://doi.org/10.1182/blood.V124.21.5630.5630
Published: 2014
Journal Articles

Predictors of Unsuccessful Mobilization with Granulocyte-Colony Stimulating Factor (G-CSF) Alone In Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell (AHSCT) Transplant

Signy Chow, MD, D. George Ormond, BSc, Alejandro Lazo-Langner, MD, MSC, Kang Howson-Jan, MD, Anargyros Xenocostas, MD, FRCPC
Journal: Blood
Blood (2010) 116 (21): 4445.
https://doi.org/10.1182/blood.V116.21.4445.4445
Published: 2010